Position in GRFS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$171,306
-$7,474 QoQ
Shares Held
21,360
+11.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0%
Shared 30%
None 70%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $2,389,117,165 across 15 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
747,548 | $896,631,571 | |
| 2 | JNJ |
Johnson & Johnson
|
1,872,006 | $475,433,362 | |
| 3 | ABBV |
AbbVie Inc.
|
1,275,203 | $320,892,081 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,567,712 | $201,450,991 | |
| 5 | AMGN |
Amgen Inc
|
444,842 | $161,086,184 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,277,451 | $73,606,725 | |
| 7 | AZN |
Astrazeneca PLC
|
318,625 | $60,417,671 | |
| 8 | NVS |
Novartis AG
|
334,595 | $52,437,727 |
All Filings in GRFS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $171,306 | 21,360 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $178,780 | 19,121 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $179,180 | 17,990 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $178,666 | 19,764 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $158,225 | 22,254 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $134,850 | 18,125 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $180,406 | 20,316 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $115,024 | 18,229 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $167,541 | 25,081 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $534,441 | 46,232 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $448,435 | 49,063 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $483,263 | 52,758 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $365,839 | 49,639 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $354,186 | 41,669 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $486,824 | 79,030 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $703,699 | 59,234 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $152,245 | 13,557 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||